Neoatricon is used to treat hypotension (low blood pressure) in newborn babies, infants and children less than 18 years of age who have unstable blood pressure. Neoatricon contains the active substance dopamine hydrochloride and is a hybrid medicine. This means that it is similar to a reference medicine containing the same active substance, but there are certain differences between the two. Unlike the reference medicine (Sterile Dopamine Concentrate BP 40mg/mL, Ireland), Neoatricon is used in children and its strength and what it is used for are different from those of the reference medicine.
Therapeutic Indication
### Therapeutic indication Treatment of hypotension in haemodynamically unstable neonates, infants and children < 18 years
Therapeutic Area (MeSH)
ATC Code
C01CA04
ATC Item
dopamine
Pharmacotherapeutic Group
Cardiac therapy
Active Substance (Summary)
INN / Common Names
EMA Name
Neoatricon
Medicine Name
Neoatricon
Aliases
N/ANo risk management plan link.
